Michael Levin

What's Ailing the Pharmaceutical Sector?

Yes, that is true, but they will still make $ and develop newer drugs and raise the bar for pricing anyway.

There are always "reasons" why some stocks go on sale and then there are "reasons" why they eventually go up again.

Merck went from $26 in November 2006 to $61 in December of 2008, a span of 25 months and in 6 months it has given back almost exactly 75% of the gains.

I would think that some consolidation or "relief rally" of sorts is in order here, now at this level of $35